Contraception

Article	Citations
Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification	92
Copyright info/Contents	80
From training to implementation: Improving contraceptive practices in South Carolina	66
CLINICAL ORAL ABSTRACTS	62
GeneFlex—A Chinese generic intrauterine device not to be confused with GyneFix	53
Addendum to “Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study” [Contraception 131 (2024) 110344]	50
“IT DEPENDS ON THE PERSON AND…ON THE SITUATION TOO”: FACTORS INFLUENCING ABORTION METHOD PREFERENCES AMONG BLACK AND LATINX COMMUNITIES IN THE US SOUTHEAST	40
Editorial Board	39
CHANGES IN BELIEFS ABOUT ABORTION SAFETY IN A NATIONALLY REPRESENTATIVE SAMPLE BETWEEN 2022 AND 2023	39
PHARMACIST ATTITUDES TOWARDS ADMINISTRATION OF DEPOT-MEDROXYPROGESTERONE ACETATE FOR CONTRACEPTION IN THE OUTPATIENT SETTING	38
THE INTERSECTION OF ENGLISH PROFICIENCY AND NATIVITY IN RECEIPT OF PERSON-CENTERED CONTRACEPTIVE COUNSELING	37
ABORTION CARE PREFERENCES AND TRADE-OFFS WHEN TRAVELING OUT OF STATE FOR FACILITY-BASED SERVICES	35
When doctors are “doxxed:” An analysis of information posted on an antiabortion website	34
ASSOCIATION OF EXPANDED MEDICAID COVERAGE TO 12 MONTHS POSTPARTUM WITH CONTRACEPTIVE USE IN SOUTH CAROLINA	34
Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access	33
Copyright info/Contents	33
Perceptions of Legality and Availability of Abortion Care in Mississippi	32
Abortion research that matters: Using core outcomes to enable systematic review	31
Society of Family Planning Annual Meeting 2022	28
O20Trauma responsive abortion care (on trac study): The abortion experiences of patients with a history of trauma	24
Copyright info/Contents	23
P010Healthcare at the margins: The role of healthcare providers in self-managed abortion near the us-mexico border	23
The role of advanced training in family planning and reproductive health in a low-income country; the experience of Ethiopia	23
P025Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment	23
P081And then what happened? Assessing contraceptive use outcomes over three years among participants in the her salt lake contraceptive initiative	22

Effect of neighborhood-level income on access to emergency contraception	22
Complex family planning and pediatric hematology oncology integrated clinic for young people with blood disorders and heavy or abnormal menstrual bleeding	21
Prescription opioid fills following surgical abortion	21
Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients	21
Use of a contraceptive decision support tool in the abortion care setting	20
Integrating anti-violence efforts into sexual and reproductive health: Reproductive coercion as a case example	20
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens	20
Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product	20
Fetal tissue donation for research at the time of abortion: A qualitative study of individuals who experienced an abortion in Hawaii in 2018-19	20
A pilot quasi-experimental controlled trial of a community-based, multilevel family planning intervention for couples in rural Uganda: evidence of feasibility, acceptability, and effect on contracepti	20
Association of body mass index on time to fetal expulsion for individuals undergoing medication abortion over 13 weeks gestational duration	19
Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist	19
Editorial Board	19
Money and place: Quantifying the types of obstacles associated with seeking an abortion after 10 weeks’ gestation, 2019–2020	19
Fetomaternal hemorrhage assessment in Rh-negative patients undergoing dilation and evacuation between 20 and 24 weeks’ gestational age: A retrospective cohort study	19
Vomiting and risk of endotracheal intubation related to preoperative doxycycline use for dilation and evacuation	19
PREDICTORS OF ABORTION PROVISION AMONG OBSTETRICIAN-GYNECOLOGISTS IN MASSACHUSETTS	18
POSTER ABSTRACTS	17
Society of Family Planning Committee Statement: Contraceptive considerations for individuals with cancer and cancer survivors part 1 – Key considerations for clinical care Joint with the Society of Gy	17
Delivery of home-based postpartum contraception in Southwest Trifinio, Guatemala: Reach, adoption, and implementation in a cluster-randomized trial	17
Copyright info/Contents	17
Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception	17
“So that I can trust them with my body:” How people with low incomes who may become pregnant define and prioritize quality reproductive health care	16
Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptive	16
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel	16
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens	16
Missing mifepristone at tribal health facilities serving native Americans	16
Social and provider networks and women's contraceptive use: Evidence from Madagascar	16
Family medicine provision of online medication abortion in three US states during COVID-19	15
NEIGHBORHOOD-LEVEL RACIALIZED SOCIOECONOMIC DEPRIVATION AND CONTRACEPTIVE USE IN THE US, 2011–2019	14
POSTER ABSTRACTS	14
Classification of periviable pregnancy-ending interventions for maternal life endangerment as induced abortion	14
HAVE WE EXPANDED ACCESS? THE IMPACT OF ABORTION TELEHEALTH IN A STATE WITH EXTENSIVE REPRODUCTIVE HEALTH DESERTS	14
Pharmacist provision of medication abortion: A pilot study	14
P091Impact of adverse childhood experiences, anxiety, and resilience on pain during office manual uterine aspiration	14
Health care access and contraceptive use among adult women in the United States in 2017	14
MOTIVATIONS TO INITIATE AND CONTINUE CONTRACEPTIVE USE AMONG SEXUAL MINORITY YOUNG WOMEN IN THE SOUTHEASTERN US	13
Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized	13
Management of cesarean scar ectopic pregnancies at an academic referral center: A case series	13
Unintended pregnancy among U.S. military active duty servicemembers: Estimates for 2018 and trends since 2005	13
Telehealth contraceptive care in 2018: A quality improvement study of barriers to access and patient satisfaction	13
O18Trends in copper versus hormonal intrauterine device breakage reporting within the us food and drug administration adverse event reporting system	13
P038Ketamine versus fentanyl for surgical abortions: A randomized noninferiority trial	13
Changes in contraceptive use during the second COVID-19 lockdown in Brazil: A web-based survey	13
“AY, CÁLLATE, GROSERA. NO DIGAS ESO”: LEARNING ABOUT SEXUALITY AMONG MIDDLE TO OLDER AGE LATINAS IN THE PACIFIC NORTHWEST	12
Contraceptive care experiences and preferences among Black women in Mississippi: A qualitative study	12
Copyright info/Contents	12
Development of the Person-Centered Contraceptive Counseling scale (PCCC), a short form of the Interpersonal Quality of Family Planning care scale	12
POST-PLACENTAL LNG-IUD OUTCOMES AT A LARGE COUNTY HOSPITAL IN TEXAS	12
Society of Family Planning Clinical Recommendation: Prevention of infection after abortion and pregnancy loss	12

Immediate postpartum contraceptive implant placement and breastfeeding success in postpartum people at risk for low milk supply: A randomized non-inferiority trial	12
Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study	11
Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus	11
Patient-reported experience with discussion of all options during pregnancy options counseling in the US South	11
PERINATAL NURSING BEREAVEMENT WORKSHOP - TRAINING FOR CRITICAL PERINATAL PATIENTS	11
O19Experiences of racial/ethnic discrimination and contraceptive use: A longitudinal study	11
POSTER ABSTRACTS	11
“The right thing to do would be to provide care… and we can’t”: Provider experiences with Georgia’s 22-week abortion ban	11
Contraceptive provision in Oregon school-based health centers: Method type trends and the role of Title X	11
Ohio survey data assessing perceptions of abortion safety	11
POSTER ABSTRACTS	11
Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007–2016, by term and preterm birth	11
Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol	11
POSTER ABSTRACTS	11
FUNCTIONAL RECOVERY AFTER SURGICAL UTERINE EVACUATION	11
Editorial Board	11
Suspected hepatotoxicity from etonogestrel contraceptive implant: A rare case report	10
Individual, partner, and community variables associated with method-specific contraceptive beliefs in urban and rural Kenya	10
POSTER ABSTRACTS	10
Expulsion of a fragmented laminaria one week after a same-day dilation and evacuation procedure	10
Patient opinions on sexual and reproductive health services in primary care in rural and urban clinics	10
A statewide analysis of uptake of highly effective contraception offered immediately postpartum in Massachusetts, 2017–2021	10
How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?	10
Society of Family Planning Clinical Recommendation: Management of hemorrhage at the time of abortion	10
Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized contro	10
P084The role of pediatric subspecialists in adolescent and young adult contraceptive care	10
DISTANCE TRAVELED TO OBTAIN ABORTION CARE IN SOUTHERN ILLINOIS BEFORE AND AFTER THE DOBBS V JACKSON WOMEN’S HEALTH ORGANIZATION DECISION	10
TEMPORARILY WITHDRAWN: Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12	10
Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use	10
POSTER ABSTRACTS	10
P019Illinois patient experiences with public and private insurance coverage for abortion following policy change	10
Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss	10
An exploratory examination of attitudes toward illegal abortion in the U.S. through endorsement of various punishments	10
Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care	9
EXPERIENCES OF COST-RELATED DELAYS ACCESSING ABORTION CARE AND PRE-ABORTION PSYCHOLOGICAL WELL-BEING	9
Pelvic examination under anesthesia by learners at the time of abortion: Who accepts and who declines?	9
Editorial Board	9
EXAMINING “BELIEFS” ABOUT ABORTION--WHAT IS ABORTION AND HOW SHOULD ABORTION BE REGULATED: FINDINGS FROM A MULTI-STATE CROSS-SECTIONAL SURVEY.	9
P030Interest in rh testing and rho(d) immune globulin received among patients obtaining first-trimester medication abortion through virtual clinics	9
P007Accuracy of self-assessment of pregnancy duration eligibility for medication abortion among young people: The advantages of expanding screening questions beyond date of last menstrual period	9
“THAT’S A TRICKY ONE”: ACCESS TO MISOPROSTOL FOR EARLY PREGNANCY LOSS IN RETAIL PHARMACIES ACROSS ARIZONA	9
EVALUATION OF A VIRTUAL “NO TOUCH” ABORTION PROGRAM IMPLEMENTED IN THE GREATER TORONTO AREA DURING THE COVID-19 PANDEMIC	9
Sampling strategies among studies of barriers to abortion in the United States: A scoping review of abortion access research	8
Contextualizing barriers to long-acting reversible contraception in Delaware	8
Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone)	8
Variation in the interpretation and application of the Medicaid sterilization consent form among Medicaid officials	8
POSTER ABSTRACTS	8
Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China	8
ABORTION TRENDS AT A SINGLE CLINIC IN SOUTHERN ILLINOIS BEFORE AND AFTER THE DOBBS V. JACKSON WOMEN’S HEALTH ORGANIZATION DECISION	8
The disproportionate burdens of the mifepristone REMS	8
Beyond stigma: Clinician bias in contraceptive counseling to sexual and gender minority youth	8
Where do female contraceptive users get their methods, and does this differ by insurance coverage? A state-level examination	8
Abortion in women with severe preeclampsia and eclampsia prior to 24 weeks gestation	8
Decomposition analysis of racial and ethnic differences in receipt of immediate postpartum, long-acting, reversible, and permanent contraception	8
Trajectories of method dissatisfaction among Kenyan women using modern, reversible contraception: A prospective cohort study	8
ABORTION PATIENTS’ AWARENESS AND UNDERSTANDING OF AN EARLY PREGNANCY ABORTION BAN AND ACCESS TO IN-STATE CARE	8
RISK FACTORS FOR SHORT-INTERVAL BIRTHS POST IPP LARC PLACEMENT IN TENNESSEE	8
Understanding medication abortion ineligibility due to gestational age among a cohort of patients in Southern California	8
Drug-drug interactions between antiretrovirals and hormonal contraception: An updated systematic review	8
Pharmacy Deserts: A Complexity That Worsens Contraception Access in the United States	8
In reply to LTE: “Weighing risks and centering patients within clinical guidelines”	8
An intersectional analysis of contraceptive types chosen among sexual minority women: A nationally representative study	8
ASSESSING THE IMPACT OF HEALTH EQUITY-INFORMED QUALITY IMPROVEMENT ON CONTRACEPTIVE CARE SCREENING, COUNSELING, AND PROVISION	8
Assessment of adolescent decision-making capacity for pharmacy access to hormonal contraception	7
URGENT, EMERGENT, OR JUST MISSED? GEOPOLITICAL VARIATIONS IN THE MANAGEMENT OF EARLY PREGNANCY LOSS IN US EMERGENCY DEPARTMENTS	7
Telemedicine for medical abortion service provision in Mexico: A safety, feasibility, and acceptability study	7
Longitudinal assessment of anti-Müllerian hormone after cesarean section and influence of bilateral salpingectomy on ovarian reserve	7
WHY US MEN HAVE ABORTIONS: QUANTITATIVE AND QUALITATIVE PERSPECTIVES FROM URBAN FAMILY PLANNING CLINICS	7
ONGOING CONTRACEPTIVE GOALS FOR PATIENTS WHO DO NOT ACHIEVE DESIRED POSTPARTUM PERMANENT CONTRACEPTION PRIOR TO HOSPITAL DISCHARGE	7
Corrigendum to “Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross-sectional analysis in six South African districts” [Contraception 116	7
“That is when I understood everything”: Ideological trajectories of pro-choice female doctors in Mexico	7
PATIENT PERSPECTIVES ON OUT-OF-STATE TRAVEL FOR ABORTION CARE POST-DOBBS	7
Racial and ethnic disparities in short interval pregnancy following delivery in Catholic vs non-Catholic hospitals among California Medicaid enrollees	7
Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois	7
PREGNANCY OPTIONS CONSIDERED AMONG NEWLY PREGNANT PEOPLE IN THE SOUTHWEST US	7
“I’M NOT SOMEONE WHO WOULD EVER HAVE AN ABORTION”: MANAGING ABORTION STIGMA AFTER DIAGNOSIS OF A SEVERELY MORBID OR LETHAL FETAL CONDITION	7
Effectiveness and safety of medication abortion via telemedicine versus in-person: A cohort of pregnant people in Colombia	7
EFFICACY AND SAFETY OF THE ESTETROL/DROSPIRENONE ORAL CONTRACEPTIVE IN US STUDY PARTICIPANTS WITH AND WITHOUT OBESITY	7
CREATING A TIME-SENSITIVE DATABASE TO MEASURE STATE-LEVEL OUTPATIENT CONTRACEPTION UTILIZATION IN MEDICAID	7
P022Growing national interest and support for advance provision and over-the-counter access to medication abortion	7

Understanding the mechanical behavior of intrauterine devices during simulated removal	7
CONCURRENT ADMINISTRATION OF DEPOT MEDROXYPROGESTERONE ACETATE WITH MIFEPRISTONE MAY DECREASE MEDICATION ABORTION EFFICACY: A RETROSPECTIVE COHORT STUDY	7
ASSESSING QUALITY OF CONTRACEPTIVE COUNSELING AT A POPULATION LEVEL: AN OPPORTUNITY TO INFORM EQUITABLE CARE DELIVERY	7
Healthcare provider communication and current contraceptive use among transgender men and gender-diverse people: Results from an online, cross-sectional survey in the United States	6
WHAT INFORMATION DO PEOPLE NEED TO SUPPORT SELF-MANAGED GENDER AFFIRMING HORMONE THERAPY (GAHT) IN THE US? A QUALITATIVE EXPLORATION OF REDDIT POSTS	6
Changes to medication abortion clinical practices in response to the COVID-19 pandemic	6
Testing the validity and reliability of the Person-Centered Contraceptive Counseling (PCCC) Performance Measure in a Real-World Contraceptive Access Program	6
IMPROVING ESTIMATES OF MEDICATION ABORTION EFFECTIVENESS: THE IMPACT OF LOSS TO FOLLOW-UP	6
Editorial Board	6
P056Oral contraceptive adherence and pregnancy rates in estetrol/drospirenone pooled phase 3 trials	6
P090Perceptions of hiv risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management	6
The Voices of Doctors Who Provide Abortion Care Increase Public Support for Legal Abortion by Replacing Flawed Negative Stereotypes with Positive Images of Compassion, Skill and Conscience	6
IMMEDIATE POSTPARTUM STERILIZATION AFTER VAGINAL DELIVERY IN THE PRE-COVID AND COVID PERIODS IN NEW YORK	6
Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate	6
Editorial Board	6
Factors associated with postpartum contraceptive planning in New Zealand	6
The association between state-level abortion restrictions and maternal mortality in the United States, 1995-2017	6
Expert participation in 25 years of Wisconsin abortion policymaking	6
Remote Provision and Self-Administration of Misoprostol as Cervical Preparation for Hospital-Based Uterine Evacuation Between 14-18 Weeks	6
Featured research at the 2023 Society of Family Planning Annual Meeting	6
PUBLIC SUPPORT FOR REPORTING AND PUNISHING PEOPLE WHO USE ALCOHOL OR DRUGS WHILE PREGNANT	6
P068Navigating uncertainty: (In)fertility and reproductive planning	6
P079Etonogestrel contraceptive implant users can experience breakthrough ovulation with only two weeks of exposure to a strong cyp3a inducer	6
Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial	6
Response to Dr. Winter's letter	6
ESTIMATING EMERGENCY CONTRACEPTION EFFICACY WITH LEVONORGESTREL AND COPPER INTRAUTERINE DEVICES	6
Impact of new abortion restrictions on people in prison: Estimated number of incarcerated people without abortion access and distance to abortion providers	6
Procedural abortion in individuals with opioid dependence: patient characteristics and pain experience	6
P064Depression after 12-month use of oral or intrauterine contraception	6
Factors associated with a negative Patient Acceptable Symptom State (PASS) response with intrauterine device placement: A retrospective survey of HER Salt Lake participants	6
REPORTED ABORTION TRAINING OPPORTUNITIES AMONG TEXAS PGY-1 OB-GYN RESIDENTS AFTER THE FALL OF ROE	6
EXPLORING THE IMPACTS OF DOBBS DECISION ON ABORTION TRAINING AT RYAN PROGRAMS	6
Male contraception – Part of gender medicine and reproductive rights of men	6
P092Measuring utilization of mifepristone in medication management of missed abortions: Retrospective claims analysis study	6
Copyright info/Contents	6
Association of willingness to use hormonal contraception with knowledge: A national survey	5
ASSOCIATION BETWEEN EXPERIENCES OF DISCRIMINATION AND CONCERNS ABOUT ACCESSING CONTRACEPTIVE CARE AMONG COMMUNITY COLLEGE STUDENTS IN TEXAS AND CALIFORNIA	5
POSTER ABSTRACTS	5
“It was close enough, but it wasn't close enough”: A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care	5
Patient Acceptability of Asynchronous vs Synchronous Telehealth Abortion Care: A Cohort Study of Telehealth Abortion Care Provided by Virtual Clinics in the United States	5
Accessibility of oral emergency contraceptives in Australian community pharmacies	5
Estetrol/Drospirenone safety in a population with cardiovascular risk factors	5
Helping patients choose between pain control options for outpatient procedural abortion at less than 12 weeks' gestation	5
Abortion at 12 or more weeks’ gestation and travel for later abortion care among Mississippi residents	5
Changes needed in Medicaid coverage and reimbursement to meet an evolving abortion care landscape	5
Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.	5
ADAPTATION AND VALIDATION OF THE CONTRACEPTIVE AGENCY SCALE FOR THE US	5
ORAL ABSTRACTS	5
SOCIAL SCIENCE ORAL ABSTRACTS	5
Exploring the experience of IUD self-removal in the United States through posts on internet forums	5
The experience of pain in real-time during medication abortion	5
CLINICAL ORAL ABSTRACTS	5
Copyright info/Contents	5
Society of Family Planning Research Practice Support: Approaching the concepts of gender and sex in family planning research	5
Catholic sole community hospitals are associated with decreased receipt of postpartum permanent contraception among Medicaid recipients	5
Society of Family Planning clinical recommendations: Contraception and abortion care for persons who use substances	5
LEVONORGESTREL 52 MG INTRAUTERINE DEVICE PLACEMENT WITHOUT SOUNDING: A FEASIBILITY STUDY	5
POSTER ABSTRACTS	5
The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease	5
Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation	5
Effectiveness and safety of a direct-to-patient telehealth service providing medication abortion targeted at rural and remote populations: Cross-sectional findings from Marie Stopes Australia	5
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study	5
Intrauterine device self-removal practices during the COVID-19 pandemic among family planning clinics	5
O17Immediate postpartum contraceptive implant placement and breastfeeding success in women at risk for low milk supply: A randomized non-inferiority trial	5
Provider perspectives on patient-centered contraceptive counseling for Latinas in Baltimore, MD	5
Copyright info/Contents	4
CHANGE IN CLINIC VOLUME AND GESTATIONAL AGE AT TIME OF ABORTION IN SOUTHERN ILLINOIS BEFORE AND AFTER DOBBS V JACKSON WOMEN’S HEALTH ORGANIZATION	4
Use of nonpreferred contraceptive methods among women in Ohio	4
POSTER ABSTRACTS	4
Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016–17 Zika virus outbreak	4
POSTER ABSTRACTS	4
Potential effect of immediate postpartum use of injectable contraception on lactogenesis	4
“We're called upon to be nonjudgmental”: A qualitative exploration of United States medical students’ discussions of abortion as a reflection of their professionalism	4
PHARMACY PRESCRIBING IS ALLOWED; WHY ISN’T IT HAPPENING?	4
Editorial Board	4
Language-based acculturation is linked with reproductive autonomy among Oregon Mexican-origin Latinas	4
Supporting Self-Managed Medication Abortion: Care Needs and Preferences of SMMA Users in Three US States	4
Population differences in responses to male hormonal contraception (lessons learned from the WHO-CONRAD phase III study)	4
CHARACTERIZING THE SEXUAL AND REPRODUCTIVE HEALTH NEEDS OF WOMEN EXPERIENCING HOUSING INSTABILITY FROM THE NATIONAL SURVEY OF FAMILY GROWTH, 2017–2019	4
Amenorrhea in adolescents using the etonogestrel contraceptive implant	4
Is it an abortion: Classification of pregnancy-ending interventions after 24 weeks in the presence of lethal fetal anomalies	4
Building the capacity of young professionals in family planning to publish: Insights from the ICFP2022 WHO scientific writing, mentoring and coaching course	4
Do miscarriage care practice recommendations align with individuals’ needs?: A scoping review	4
P083The impact of federal and state-level contraceptive coverage policies on contraceptive cost and use among privately insured women	4
Unanswered questions from abortion seekers: An application of the Research Prioritization by the Affected Community (RPAC) protocol in the Central Valley, California	4
Effectiveness of training primary care internal medicine residents in etonogestrel implants and impact on their future practice: A cross-sectional study	4
A case report of eosinophilia associated with an etonogestrel implant	4
NAVIGATING CRISIS PREGNANCY CENTERS: A SCOPING REVIEW	4
POSTER ABSTRACTS	4
Copyright info/Contents	4
POSTER ABSTRACTS	4
O12Barriers to abortion access for young southerners: a qualitative analysis of case notes from arc-southeast	4
Editorial Board	4
Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross sectional analysis in six South African districts	4
P003“We are completely captured”: The influence of us foreign policy through the global gag rule on malawi's sexual and reproductive health and rights landscape	4